TERRA Phase 2 Study of ACG-701 Continues Without Modification
EXTON, PA — Aceragen, Inc. (Nasdaq: ACGN) announced the recent recommendation of its independent Data Monitoring Committee (DMC) in regard to the on-going TERRA Phase 2 study of ACG-701 in …
TERRA Phase 2 Study of ACG-701 Continues Without Modification Read More